Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Artimplant Interim Report January 1 - March 31, 2007.


VASTRA FROLUNDA, Sweden -- * Net revenue of SEK SEK

In currencies, this is the abbreviation for the Swedish Krona.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 3.9 million (1.1)(a)

* Net loss of SEK 2.9 million (10.4)

* Earnings per share of SEK -0.05 (SEK -0.17)

* Strong sales increase for Artelon[R] CMC (Common Messaging Calls) A programming interface specified by the XAPIA as the standard messaging API for X.400 and other messaging systems. CMC is intended to provide a common API for applications that want to become mail enabled.

1.
 Spacer - around 1,300 (400) units were sold to end-customers during Q1 2007

* More than 4,000 patients had been treated with Artelon[R] devices through to Q1 2007

(a) Figures in brackets refer to the corresponding period last year.

The Company will not hold any conference call this quarter.

About Artimplant

Artimplant (STO:ARTIB) is a biomaterials company focused on solutions to problems in orthopedic and oral surgery. We restore health through the development, production, and marketing of degradable de·grad·a·ble  
adj.
That can be chemically degraded: degradable plastic wastes.



de·grad
 implants that regenerate body functions and improve quality of life. Our products, made from Artelon[R], meet unmet clinical needs and are marketed in a growing number of therapy areas. Artimplant produces implants for treatment of osteoarthritis osteoarthritis
 or osteoarthrosis or degenerative joint disease

Most common joint disorder, afflicting over 80% of those who reach age 70. It does not involve excessive inflammation and may have no symptoms, especially at first.
 in hands and feet, for shoulder and other soft tissue injuries as well as oral applications.

Artimplant is a public company listed on the OMX OMX Office Max (stock symbol)  Nordic Exchange Stockholm in the Small Cap segment and in the healthcare sector.

Forward-looking statements

This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting the Company's business including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence ob·so·les·cent  
adj.
1. Being in the process of passing out of use or usefulness; becoming obsolete.

2. Biology Gradually disappearing; imperfectly or only slightly developed.
; general economic conditions; and other risks detailed from time to time in the Company's filings.

This information was brought to you by Cision http://newsroom.cision.com
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 3, 2007
Words:298
Previous Article:Andre B. Sassine Promoted to Senior Vice President at Hill International.
Next Article:Home Health Care Services Analysis Based On Data Applied From 17,268 Industry Firms on A State-By-State Basis for the US.



Related Articles
Artimplant: Nine-month report 2000.
Artimplant Interim Report January 1 - June 30, 2001.
Comments requested on interim final rules to the Fair and Accurate Transactions Act of 2003.
Artimplant: Presentation of Artimplant's Interim Report January - June 2006 on August 8, 2006.
Artimplant: Invitation to Artimplant's Capital Market Day on November 16, 2006.
ORIX Announces Interim (April 1-September 30) Net Income Up 9% Year on Year to 91.3 Billion Yen.
Kobayashi Pharmaceutical Reports Financial Results for the First Half Ended Sept. 30, 2006.
Asahi Kasei Announces Revision of Plan for Year-end Dividend.
OMRON Announcement of Increased Dividend Forecast for Fiscal Year Ending March 31, 2007.
OMRON Reports Record Results for the Full Year Ended March 31, 2007.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles